In this study, we investigated the potential contribution of CD36 rare mutations to T2D and its cardio-metabolic complications (i.e. hypertension, dyslipidemia and history of coronary heart disease) by screening 184 French cases of European ancestry. This evidence concerns the gene CD36 and metabolic syndrome.